Diana Berry

Jun 25, 2024 | link.iise.org | Keith Albertson |Diana Berry |Luca Collina |Mostafa Sayyadi

FEATURESExperts at Atlanta expo discuss industry’s challenges, changesBy Keith AlbertsonCompanies should adopt strategies to develop high performers By Diana BerryISE summer interns share their learning experiencesMaster a strategy to overcome data quality, integrity challenges By Luca Collina, Mostafa Sayyadi and Michael J. Provitera

Jun 6, 2024 | healthenews.mcgill.ca | Diana Berry |Asma Ahmed

A groundbreaking project led by The GCI’s Michel L. Tremblay, Ph.D., and McGill University’s David Langlais, Ph.D., secures significant funding from Genome Canada. The initiative focuses on enhancing cancer immunotherapy by harnessing Natural Killer (NK) cells, aiming to develop a potent, pharmacologically activated NK cell bank for widespread cancer treatment, potentially revolutionizing patient care. Read more.

May 17, 2024 | healthenews.mcgill.ca | Diana Berry |Asma Ahmed

Melanoma is the rarest, but also the deadliest form of skin cancer, and is the source of both common misconceptions as well as next-generation cancer research. Unlike other skin cancers which arise from the cells that make up the layers of the skin, melanoma originates in the skin’s pigment producing cells called melanocytes.

Mar 13, 2024 | healthenews.mcgill.ca | Diana Berry |Asma Ahmed

The focus of the Kazak lab is understanding energy metabolism in physiology and disease, with research interests extending to cancer cell metabolism and immunity. His cutting-edge research and distinction as an outstanding young investigator prompted his nomination for this award. “Lawrence Kazak is an exceptional scientist, a pillar of the GCI community who has already distinguished himself through notable contributions to his field,” shared Morag Park, Ph.D., Director of the GCI.

Nov 30, 2023 | healthenews.mcgill.ca | Diana Berry |Asma Ahmed

Canadian Cancer Society scholarship recipient: Alyssa CristeaAlyssa Cristea is a master’s student in the second year of the Experimental Medicine program. She is supervised by Dr. Daniela Quail. Her research focuses on obesity, which is estimated to promote 14-20% of all cancer deaths. One type of cancer strongly affected by obesity is colorectal cancer, which accounts for 10% of all new cancer cases in Canada.